Please check your internet connection and try again.
# Intravenous Dexamethasone
## Overview
Dexamethasone is a potent synthetic corticosteroid with anti-inflammatory and immunosuppressive effects.
## Primary Indications
* Allergic states
* Dermatologic conditions
* Endocrine disorders
* Gastrointestinal diseases
* Hematologic conditions
* Neoplastic disease (palliative treatment of certain cancers)
* Nervous system conditions (e.g., cerebral edema)
* Ophthalmic diseases
* Renal disease
* Respiratory diseases
* Rheumatic disorders
* Exacerbations of multiple sclerosis
* Adjunct treatment in septic shock
## Adult Dosing
Dosing is highly variable depending on the indication and severity. Specific protocols are often utilized.
* **Cerebral Edema:** Initial dose 10 mg IV, followed by 4 mg IV every 6 hours, usually tapering over several days.
* **Allergic Reactions/Asthma Exacerbation:** 4-24 mg IV every 6-24 hours.
* **Septic Shock:** Historically used, but current guidelines do not routinely recommend for septic shock. If used, 20 mg IV once, or 10 mg IV every 6 hours for 4-7 days.
* **Multiple Sclerosis Exacerbation:** 4 mg IV every 6 hours for 3 days, followed by 4 mg PO daily for 3 days.
## Pediatric Dosing
Dosing is typically based on weight and indication, and often requires specialist consultation.
* **Cerebral Edema:** 0.1-0.2 mg/kg/dose IV every 6-12 hours. Maximum dose typically 8 mg/day.
* **Allergic/Inflammatory:** Dosing is highly variable and often follows adult protocols with weight-based adjustments.
## Dose Adjustments
* **Hepatic Impairment:** May require dose reduction in severe hepatic impairment due to potential for decreased metabolism.
* **Renal Impairment:** No dose adjustment is typically required, but monitor for adverse effects.
## Contraindications
* Systemic fungal infections
* Hypersensitivity to dexamethasone or other components of the formulation
## Adverse Effects
Common: Hyperglycemia, increased appetite, weight gain, fluid retention, mood changes (euphoria, insomnia, psychosis), increased susceptibility to infection, peptic ulceration, adrenal suppression, growth suppression (pediatrics). Less common: Osteoporosis, muscle weakness, Cushingoid appearance, skin thinning, striae, acne.
## Key Drug Interactions
* **CYP3A4 Inducers (e.g., phenytoin, rifampin, carbamazepine, phenobarbital):** May increase dexamethasone clearance, requiring higher doses.
* **CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole, macrolides):** May decrease dexamethasone clearance, potentially increasing toxicity.
* **Anticoagulants (e.g., warfarin):** Corticosteroids may alter the anticoagulant response. Monitor INR closely.
* **Diuretics (e.g., loop diuretics, thiazides):** Increased risk of hypokalemia.
* **Antidiabetic agents:** May cause hyperglycemia, requiring adjustment of antidiabetic therapy.
* **Vaccines:** Live vaccines are contraindicated due to immunosuppression. Reduced response to inactivated vaccines.
## Monitoring
* Blood glucose
* Electrolytes (potassium, sodium)
* Signs of infection
* Bone mineral density (long-term therapy)
* Growth (pediatrics)
* Adrenal function (during and after long-term therapy)
* Psychiatric status
## Clinical Pearls
* Stress doses may be required during periods of illness, surgery, or trauma in patients on chronic corticosteroid therapy.
* Tapering of the dose is crucial to prevent adrenal insufficiency when discontinuing chronic therapy.
* Dexamethasone is a "low salt-syndrome" steroid, meaning it causes less sodium and water retention than other corticosteroids.
* Intravenous administration bypasses first-pass metabolism and provides rapid onset of action.
***
*Disclaimer: This information is intended for educational purposes and does not substitute for professional medical advice. Always consult the most current prescribing information and your healthcare provider for any health concerns or before making any decisions related to your health or treatment.*
